Join CBSET's partner CILcare at the 3rd annual Neuropsychiatric Drug Development Summit November 10-12, 2020, 2020.
Returning as an interactive, virtual meeting, this definitive industry meeting is focused on helping companies develop the next generation of more clinically effective therapeutics. With an emphasis on depressive disorders, schizophrenia, addiction and PTSD, this timely meeting provides a much-needed platform for industry and academic thought leaders.
Registration information is here.
Please contact us to schedule an e-meeting before, during or after the virtual Neuropsychiatric Drug Development Summit.